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Abstract
Nocturnal symptoms are common in asthma, even when patients are regularly seen
at an outpatient clinic. Inflammation is generally accepted as a general feature of
asthma and the severity of this basic inflammatory process can be increased by
exogenous triggers such as exposure to allergens and non-allergic stimuli.
Superimposed endogenous circadian rhythms may play a more important and
intricate role in the circadian modulation of the inflammatory process by changing
the number of cells, their release of mediators and/or the susceptibility of airway
smooth muscle and vasculature. For instance, an increase in vagal tone may induce
nocturnal bronchoconstriction which is further enhanced by falling catecholamine
levels. Together, the reduced nocturnal catecholamine levels and the diminished
bronchodilating capacity of the NANC system and the low cortisol levels oppose
possible protection against inflammatory processes leading to nocturnal airflow
obstruction.
Introduction
Nocturnal symptoms of dyspnoea and wheezing are common in asthmatic patients
and are thought to be related to the severity of the disease (1). Both in healthy
subjects and asthmatic patients a circadian variation in airway diameter exists, with
best lung function values during the day and worst values at night. In healthy
subjects differences between daytime and nighttime values are small, in asthmatic
patients they may be large with the consequence of nocturnal airflow limitation and
symptoms such as cough, wheeze, dyspnoea and waking up.
Although nocturnal complaints of asthma have been recognized for a long time,
little is known about its epidemiology. The mechanisms that contribute to the
amplified 24 hours swings in pulmonary function are not yet fully clear but the
concept is growing. In this article we will focus on both epidemiology and
pathophysiology and try to come to a concept of mechanisms that play a role in
nocturnal asthma.
Epidemiology
Throughout history the occurrence of nocturnal complaints of asthma have been
reported (2).
In 1973 the first epidemiological study on the prevalence of nocturnal asthma
appeared and was repeated in 1988. Turner-Warwick showed in 1988 that 39% of a
non-hospital-based population in the United Kingdom woke up every night, 64%
woke up at least 3 nights per week and 74% woke up at least 1 night per week (3).
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These data were comparable to those of the study 15 yrs earlier, and the author
concluded that not much had changed despite the introduction of inhaled
corticosteroids.
In 1991 we studied the epidemiology of nocturnal complaints and early morning
dyspnoea in 796 asthmatic children from our own outpatient clinic. The
questionnaire referred to the last 3 weeks before a regular control visit. Forty seven
percent reported nocturnal complaints or early morning dyspnoea. Only 6%
reported to have complaints every night. In our population as well as in the study
population from the United Kingdom about half of the patients used inhaled
corticosteroids, drugs known to reduce the 24 hour amplitude of the lung function.
The difference in results between the two studies may be explained by differences
in age of the study populations and probably differences in frequency of medical
control, since the population studied by Turner-Warwick was only defined as
patients for whom an inhaled bronchodilator was prescribed by a general physician.
Despite differences in outcome of the two studies, we have to conclude that
nocturnal symptoms of asthma are still common in the nineties even in a regularly
controlled asthmatic population.
Mechanisms
Both exogenous triggers, and probably more important, circadian variations in
endogenous mechanisms, such as bronchial responsiveness, the autonomic central
nervous system and cortisol secretion, modulate the inflammatory processes in the
airways underlying the asthmatic expression. This may ultimately result in variation
of the airway diameter over 24 hours.
BRONCHIAL RESPONSIVENESS
The increase in airflow obstruction during the night was thought to be a
consequence of the increase in bronchial responsiveness that was observed at the
same time (4). However, in asthmatic children we found that the circadian variation
in bronchial responsiveness can be independent of the degree of airflow obstruction
(5) as confirmed by Bonnet et al. (6). This indicates that an increase in bronchial
responsiveness overnight in itself is not responsible for nocturnal airflow
obstruction and that other factors are involved.
CORTISOL
Corticosteroids are well-known for their beneficial effect in restoring pulmonary
function in severe asthma attacks with a latency of several hours. The circadian
variation in serum cortisol shows trough levels at 01.00 h and peak levels about
08.00 h. Postma et al. (7) observed levels of serum cortisol in patients with chronic
obstructive pulmonary disease (COPD) comparable to those in the matched healthy
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controls. Together with the observation that infusion of cortisol did not prevent the
nocturnal fall in pulmonary function in five out of six patients (8) has led to the
believe that the fall in cortisol during the early night is not in itself responsible for
the decrease in airway diameter at 04.00 h.
THE AUTONOMIC NERVOUS SYSTEM
The circadian variation in airway diameter is known to be under control of various
components of the autonomic nervous system such as the parasympathetic system,
ß-adrenergic sympathetic system and the non-adrenergic non-cholinergic (NANC)
system.
The parasympathetic system
Increased parasympathetic tone causes a decrease in the airway diameter. In adult
patients with asthma and in patients with COPD an increase in parasympathetic
activity was observed during the night (9,10). We were unable to confirm this
finding in children with nocturnal asthma (11). Moreover, after heart-lung trans-
plantation, when vagal innervation is lost, a circadian variation in airway diameter
is still present (12). These observations indicate that parasympathetic activity
contributes, but does not fully explain nocturnal airflow obstruction.
The ß-adrenergic system
The ß-adrenergic system is of importance for airway dilatation and consists of
circulating catecholamines and ß-receptors on cell membranes of inflammatory
cells, cholinergic ganglia and airway smooth muscle. Circulating catecholamines
such as adrenaline and noradrenaline show a circadian variation with lowest levels
at 04.00 h coinciding with the nocturnal increase in airflow obstruction. ß2-receptor
density on peripheral blood cells is also lowest during the night. These observations
suggest that the diminished bronchodilating capacity during the night is responsible
for the nocturnal increase in airflow obstruction. However, correction of the
nocturnal dip in serum adrenaline by infusion of adrenaline did not prevent the fall
in pulmonary function (10). Moreover, we did not observe differences in adrenaline
and noradrenaline urinary excretion between asthmatic children with and without
increased nocturnal airflow obstruction and their healthy controls (13). This
indicates that a fall in circulating catecholamines during the night does not have a
direct action on bronchial smooth muscle tone. This fall will provide a smaller
protective effect on for instance mast cells, thereby inducing histamine and other
mediator release (13). Furthermore, increasing vagal tone can be opposed by inhi-
bition of cholinergic neurotransmission at the level of parasympathetic ganglia and
may permit an increase in microvascular leakage, ultimately leading to an increase
in airflow obstruction.
The non-adrenergic non-cholinergic system
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A circadian variation in NANC neurotransmission has been found as well: a
decreased bronchodilator response upon stimulation with capsaicin was found at
04.00 h as compared to 16.00 h in healthy subjects and in asthmatics (14). This
decreased bronchodilator response in the morning may result from central modula-
tion of the stimulus or from inhibition of the efferent activity. The authors
concluded that nocturnal airflow obstruction in asthmatic subjects may be partly
caused by a decreased NANC bronchodilatation.
Concept of mechanisms in nocturnal asthma
It is generally accepted that a specific inflammatory process underlies the
pathogenesis of asthma. That an inflammatory process may play a role in nocturnal
asthma is supported by the observation that anti-inflammatory drugs such as inha-
led corticosteroids reduce the overnight fall in pulmonary function (15).
Martin et al. (13) showed, at least in some, but certainly not in all patients with
nocturnal asthma an increase in numbers of eosinophils and neutrophils in the
nocturnal bronchoalveolar lavage (BAL) fluid as compared to daytime numbers.
Jarjour et al. (16) did not observe day-night variations in inflammatory cells in the
BAL fluid. Lungbiopsies will probably provide an answer whether an influx and
activation of inflammatory cells in the lungs overnight are responsible for the fall
in pulmonary function.
At this time we hypothesize the inflammatory process to be a general feature in
asthma. The severity of this basic inflammatory process can be increased by exoge-
nous triggers, such as exposure to allergens and non-allergic stimuli. Superimposed
endogenous circadian rhythms may play a more important and intricate role in the
circadian modulation of the inflammatory process by changing number of cells,
their release of mediators and/or the susceptibility of airway smooth muscles and
vasculature. Increased vagal tone may induce nocturnal bronchoconstriction. Falling
catecholamine levels overnight may induce further decrease of the airway diameter.
Together with the reduced nocturnal catecholamine levels, diminished bron-
chodilating capacity of the NANC system and low cortisol levels oppose possible
protection against inflammatory processes, leading to nocturnal airflow obstruction.
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CHAPTER 1.2
AIMS OF THE THESIS
In this thesis several exogenous factors that may influence the severity of nocturnal
airflow limitation in asthmatic children are investigated. Next to the influence of
these exogenous factors we investigated the frequency of nocturnal symptoms on
our pediatric asthma outpatient clinic.
In Chapter 1.1 a concept of possible mechanisms and interactions between
endogenous and exogenous factors that may underly nocturnal airflow limitation is
discussed.
In Chapter 2 we investigated the frequency of nocturnal symptoms such as
coughing, wheezing, shortness of breath and dyspnea on awakening in the morning
in our asthmatic outpatient clinic in children with asthma.
In Chapter 3 a study is presented in which we investigated whether house dust
mite exposure levels in houses of asthmatic children are higher than in houses of
healthy controls.
In Chapter 4 a study is presented in which we investigated the wheter exogenous
factors such as environmental tobacco smoke, the presence of pets, and the levels
of house dust mite in houses of asthmatic children with a mono-allergy to house
dust mite contributed to an increased circadian peak expiratory flow amplitude.
In Chapter 5 a study is presented in which we investigated whether the seasonal
variations in house dust mite exposure contributed to an increase in circadian peak
expiratory flow amplitude in asthmatic children with a mono-allergy to house dust
mite.
In Chapter 6 we discussed that mite-specific IgE could not be used as an
alternative for house dust mite exposure in answer to a study in which the authors
suggested that that this could be done.
In Chapter 7 a study is presented in which we investigated in asthmatic children
who were already treated with inhaled corticosteroids whether 16 weeks of
treatment with the long acting ß-adrenergic drug salmeterol leads to a sustained
bronchodilator effect and decreased bronchial responsiveness during the day and
night. Furthermore, we assessed whether cessation of salmeterol after 4 months,
when added to a regime with inhaled corticosteroids, leads to a rebound increase in
bronchial responsiveness.
In Chapter 8 a study is presented in which we investigated daytime and nighttime
inflammatory parameters in healthy children and in asthmatic children treated with
inhaled corticosteroids. Moreover, we assessed whether differences in inflammation
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between healthy and asthmatic children are associated with lung function
parameters and whether long-term treatment with salmeterol influenced
inflammatory parameters.
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